Edwards Lifesciences Corp [EW] moved up 2.59: Why It’s Important

Edwards Lifesciences Corp [NYSE: EW] traded at a high on Wednesday, posting a 2.59 gain after which it closed the day’ session at $88.33.

The results of the trading session contributed to over 3197734 shares changing hands. Over the past one week, the price volatility of Edwards Lifesciences Corp stands at 2.38% while the volatility over the past one month is 2.52%.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

The market cap for EW stock reached $53.11 billion, with 601.10 million shares outstanding and 591.88 million shares in the current float. Compared to the average trading volume of 4.35M shares, EW reached a trading volume of 3197734 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Edwards Lifesciences Corp [EW]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EW shares is $92.04 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EW stock is a recommendation set at 2.17. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Wells Fargo have made an estimate for Edwards Lifesciences Corp shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on February 02, 2024. While these analysts kept the previous recommendation, Evercore ISI dropped their target price from $80 to $77. The new note on the price target was released on January 04, 2024, representing the official price target for Edwards Lifesciences Corp stock.

The Average True Range (ATR) for Edwards Lifesciences Corp is set at 2.09, with the Price to Sales ratio for EW stock in the period of the last 12 months amounting to 8.85. The Price to Book ratio for the last quarter was 7.98, with the Price to Cash per share for the same quarter was set at 2.74. Price to Free Cash Flow for EW in the course of the last twelve months was 82.63 with Quick ratio for the last quarter at 2.40.

How has EW stock performed recently?

Edwards Lifesciences Corp [EW] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 2.71. With this latest performance, EW shares gained by 2.64% in over the last four-week period, additionally plugging by 16.27% over the last 6 months – not to mention a rise of 12.09% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for EW stock in for the last two-week period is set at 64.59, with the RSI for the last a single of trading hit 65.06, and the three-weeks RSI is set at 64.23 for Edwards Lifesciences Corp [EW]. The present Moving Average for the last 50 days of trading for this stock 80.26, while it was recorded at 86.31 for the last single week of trading, and 78.07 for the last 200 days.

Edwards Lifesciences Corp [EW]: Deeper insight into the fundamentals

Edwards Lifesciences Corp’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.40 and a Current Ratio set at 3.38.

Earnings analysis for Edwards Lifesciences Corp [EW]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for EW. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Edwards Lifesciences Corp go to 9.26%.

Insider trade positions for Edwards Lifesciences Corp [EW]

The top three institutional holders of EW stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in EW stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in EW stock with ownership which is approximately 5.8325%.